Literature DB >> 10708812

The current status of the platelet 5-HT(2A) receptor in depression.

S D Mendelson1.   

Abstract

The author reviews the current status of the platelet serotonin (5-HT)(2A) receptor in depression. Considered are studies of receptor binding, and 5-HT-induced platelet activation and aggregation. 5-HT(2A) receptor density tends to increase in depression, although this more clearly relates to suicidality than depression per se. Indeed, data are consistent with the hypothesis that increased density of platelet 5-HT(2A) receptors may be a marker for increased risk of suicide. 5-HT-induced calcium mobilization is enhanced in unipolar depression; however, unlike in bipolar depression, baseline calcium levels are not. Despite inconsistencies, 5-HT-induced aggregation appears inhibited in depression. This may manifest as a relative inhibition, i.e. no change in aggregation response despite a higher density of 5-HT(2A) receptors. The inhibited aggregation response is state dependent, and acute phase proteins or components of the stress response may be factors. It is unclear if differences between depressed and normal subjects in disposition of 5-HT(2A) receptors are generally indicative of traits or states. Nonetheless, there is little evidence that the degree of departure from normal density or activity of platelet of 5-HT(2A) receptors reflects severity of depression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708812     DOI: 10.1016/s0165-0327(99)00177-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  17 in total

Review 1.  Influence of mental stress on platelet bioactivity.

Authors:  Pia Koudouovoh-Tripp; Barbara Sperner-Unterweger
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression.

Authors:  Marlene S Williams; Roy C Ziegelstein; Una D McCann; Neda F Gould; Tamara Ashvetiya; Dhananjay Vaidya
Journal:  Psychosom Med       Date:  2019-05       Impact factor: 4.312

3.  Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.

Authors:  J Roggenbach; B Müller-Oerlinghausen; L Franke; R Uebelhack; S Blank; B Ahrens
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

4.  Increased thermal and mechanical nociceptive thresholds in rats with depressive-like behaviors.

Authors:  Miao Shi; Wei-Jing Qi; Ge Gao; Jin-Yan Wang; Fei Luo
Journal:  Brain Res       Date:  2010-07-15       Impact factor: 3.252

5.  Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.

Authors:  Ghanshyam N Pandey; Subhash C Pandey; Xinguo Ren; Yogesh Dwivedi; Philip G Janicak
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 6.  Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Authors:  David Baumeister; Georgina Barnes; Giovanni Giaroli; Derek Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

7.  Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome.

Authors:  Jacob Sama; Dhananjay Vaidya; Monica Mukherjee; Marlene Williams
Journal:  J Thromb Thrombolysis       Date:  2021-04       Impact factor: 2.300

Review 8.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 9.  Inflammation, heart disease, and depression.

Authors:  Angelos Halaris
Journal:  Curr Psychiatry Rep       Date:  2013-10       Impact factor: 5.285

10.  The role of platelet serotonin and depression in the acute coronary syndrome population.

Authors:  Jennifer E Sanner; Lorraine Frazier; Malini Udtha
Journal:  Yale J Biol Med       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.